Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study.
Rafael Brolio PavãoHenrique Turin MoreiraAntonio Oswaldo PintyaJorge Luis HaddadAndré Vannuchi BadranMoysés de Oliveira Lima-FilhoIgor Matos LagoJoão Reynaldo Abbud ChiericeAndre SchmidtJose Antônio Marin NetoPublished in: Revista da Sociedade Brasileira de Medicina Tropical (2021)
This low-cost 3-month treatment for patients diagnosed with CCCD and CMD was safe and resulted in a 55.6% reduction in ischemic burden, symptomatic improvement, and better quality of life.
Keyphrases
- low cost
- coronary artery disease
- end stage renal disease
- coronary artery
- ejection fraction
- newly diagnosed
- chronic kidney disease
- low dose
- prognostic factors
- oxidative stress
- randomized controlled trial
- percutaneous coronary intervention
- cardiovascular events
- magnetic resonance imaging
- cardiovascular disease
- brain injury
- computed tomography
- aortic valve
- combination therapy
- subarachnoid hemorrhage
- cerebral ischemia